Jump to content

Liver cancer

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 173.53.178.159 (talk) at 02:50, 16 July 2010 (→‎External links). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Liver cancer
SpecialtyOncology Edit this on Wikidata

Liver cancer or hepatic cancer is properly considered to be a cancer which starts in the liver, as opposed to a cancer which originates in another organ and migrates to the liver, known as a liver metastasis. For a thorough understanding of liver cancer it is important to have an understanding of how the liver functions. The liver is one of the largest organs in the body. It is located below the right lung and under the ribcage. The liver is divided into four lobes: the right lobe, the left lobe, the caudate lobe, and the quadrate lobe. Protein is obtained by the liver from the portal vein, which carries nutrient-rich blood from the intestines to the liver. The hepatic artery supplies the liver with blood that is rich in oxygen. Liver cancer thus consists of the presence of malignant hepatic tumors, growths on or in the liver (medical terms pertaining to the liver often start in hepato, or hepatic from the Greek word for liver, hēpar, stem hēpat-). Liver tumors may be discovered on medical imaging, which may occur incidentally to imaging performed for a different disease than the cancer itself, or may present symptomatically, as an abdominal mass, abdominal pain, jaundice, nausea or some other liver dysfunction.[1]

Classification

There are many forms of liver cancer, although many cancers found in the liver are metastases from other tumors, frequently of the GI tract (like colon cancer, carcinoid tumors mainly of the appendix, etc.), but also from breast cancer, ovarian cancer, lung cancer, renal cancer, prostate cancer, etc.

The most frequent, liver cancer is hepatocellular carcinoma (HCC) (also named hepatoma, which is a misnomer because adenomas are usually benign). Patients who develop this cancer normally are in the younger population. This tumor also has a variant type that consists of both HCC and cholangiocarcinoma components. The cells of the bile duct coexist next to the bile ducts that drain the bile produced by the hepatocytes of the liver. The cancers arose from the blood vessel cells in the liver are known has hemangioendotheliomas.

As well as mixed tumors, rarer forms of liver cancer include:

  • mesenchymal tissue
  • Sarcoma
  • Hepatoblastoma, a rare malignant tumor, primarily developing in children. Most of these tumors form in the right lobe.
  • Cholangiocarcinoma (bile duct cancers), which account for 1 or 2 out of every 10 cases of liver cancer. These cancers start in the small tubes (called bile ducts) that carry bile to the intestine.
  • Angiosarcoma and hemangiosarcoma: These are rare forms of cancer that start in the blood vessels of the liver. These tumors grow quickly. Often by the time they are found they are too widespread to be removed. Most patients do not live more than a year after diagnosis.
  • Lymphoma of liver: A rare form of lymphoma that usually have diffuse infiltration to liver. It may also form a liver mass in rare occasions.

Symptoms of Liver cancer

Symptoms of Cholangiocarcinoma

Symptoms of hepatocellular carcinoma

Causes

A 2009 study suggested that l-carnitine deficiency is a risk factor for liver cancer, and that supplementation with it could reduce the risk.[4]

Japan being member of International Cancer Genome Consortium is leading efforts to map liver cancer's complete genome.

Management

A PET-CT scan may be suggested if doctors are considering surgery as a treatment. It gives more detailed information about the part of the body being scanned.[5] The correct treatment of liver cancer can mean the difference between life and death. Not all patients with cancers in the liver are potentially curable. These are some of the treatments available: Surgery, Chemotherapy, Immunotherapy, Photodynamic Therapy, Hyperthermia, Radiation Therapy and Radiosurgery.[6]

Treatment of hepatocellular carcinoma

Treatment of Cholangiocarcinoma

Treatment of hepatoblastoma

Epidemiology

Age-standardized death from liver cancer per 100,000 inhabitants in 2004.[10]
  no data
  less than 7.5
  7.5-15
  15-22.5
  22.5-30
  30-37.5
  37.5-45
  45-52.5
  52.5-60
  60-67.5
  67.5-75
  75-110
  more than 110

Liver cancer as a cause of death is reported at less than 30 cases per 100,000 inhabitants in most of the world, with higher rates observed in parts of Africa and eastern Asia.

See also

References

  1. ^ http://www.liverfoundation.org/education/info/progression/
  2. ^ <http://emedicine.medscape.com/article/277393-overview
  3. ^ http://www.childrenshospital.org/az/Site1015/mainpageS1015P0.html
  4. ^ Long-term L-carnitine supplementation prevents development of liver cancer.
  5. ^ http://www.cancerbackup.org.uk/Cancertype/Liversecondary/Causesdiagnosis/Furthertests
  6. ^ Radiosurgery treatment for liver cancer
  7. ^ http://www.mayoclinic.com/health liver-cancer/DS00399/DSECTION=treatments%2Dand%2Ddrugs
  8. ^ http://emedicine.medscape.com/article/277393-treatment
  9. ^ http://emedicine.medscape.com/article/986802-treatment
  10. ^ "WHO Disease and injury country estimates". World Health Organization. 2009. Retrieved Nov. 11, 2009. {{cite web}}: Check date values in: |accessdate= (help)

External links

<ref>http://www.clinicaltrials.gov/ct2/show/NCT00617981?term=Thermodox&rank=3)

Retrieved from "https://en.wikipedia.org/w/index.php?title=Liver_cancer&oldid=373738297"